Drug Type Small molecule drug |
Synonyms MS-1917 |
Target |
Action modulators |
Mechanism QTRT1 modulators(queuine tRNA-ribosyltransferase catalytic subunit 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | Ireland | 01 Oct 2024 |